First Tracks Biotherapeutics updates PSU holdings
First Tracks Biotherapeutics, Inc. updated its initial insider ownership report for President and CEO Daniel Faga to include 53,334 Performance Stock Units (PSUs) tied to common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
First Tracks Biotherapeutics, Inc. updated its initial insider ownership report for President and CEO Daniel Faga to include 53,334 Performance Stock Units (PSUs) tied to common stock. The PSUs carry a stated exercise price of $0.0000 per unit. According to the vesting terms, 50% of the PSUs vest and settle on March 12, 2027 and the remaining 50% on March 12, 2028, in each case subject to Faga’s continuing service with the company on the applicable vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Stock Unit F1 | -- | -- | -- |
Footnotes (1)
- F1. The PSUs vest and settle over two years; 50% vests on March 12, 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
Key Figures
Key Terms
Performance Stock Unit financial
vest and settle financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3/A for TRAX disclose about Daniel Faga’s holdings?
How many Performance Stock Units does the TRAX CEO hold after this amendment?
What is the vesting schedule of the CEO’s PSUs at First Tracks Biotherapeutics (TRAX)?
Is there an exercise or conversion price for the TRAX CEO’s Performance Stock Units?
Are the TRAX CEO’s PSUs currently vested or unvested?
AI-generated analysis. How Rhea-AI works. Not financial advice.